Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines

被引:105
作者
Gummuluru, S
Emerman, M
机构
[1] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA
关键词
D O I
10.1128/JVI.73.7.5422-5430.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Viral protein R (Vpr) of human immunodeficiency virus type 1 (HIV-1) transiently arrests cells in the G(2) phase of the cell cycle and is a weak transcriptional transactivator. We found that Vpr increased HIV-1 long terminal repeat (LTR) activity in all cells examined but, when expressed at, high levels, decreased HIV-1 LTR expression due to cytotoxic effects. Moreover, Vpr-mediated enhancement of HIV-1 LTR-driven transcription was observed in cycling primary human CD4(+) T cells hut not in terminally differentiated, noncycling primary human macrophages, In single-round infection experiments using primary human CD4(+) T cells, proviral clones expressing either wild-type Vpr or Vpr mutants that retained the ability to cause a G(2) arrest replicated to higher levels than proviruses lacking Vpr or expressing mutants of Vpr that did not cause an arrest. In support of the hypothesis that enhancement of HIV-1 LTR transcription by Vpr is an indirect effect of the ability of Vpr to delay cells in G(2), counterflow centrifugal elutriation of cells into different phases of the cell cycle demonstrated that HIV-1 LTR expression was highest in G(2). Finally, the ability of Vpr to upregulate viral transcription was dependent on a minimal promoter containing a functional TATA box and an enhancer.
引用
收藏
页码:5422 / 5430
页数:9
相关论文
共 49 条
[1]  
ABRAHAM SE, 1993, ONCOGENE, V8, P1639
[2]   CLONING AND EXPRESSION OF THE MOUSE PGK-1 GENE AND THE NUCLEOTIDE-SEQUENCE OF ITS PROMOTER [J].
ADRA, CN ;
BOER, PH ;
MCBURNEY, MW .
GENE, 1987, 60 (01) :65-74
[3]   The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB [J].
Agostini, I ;
Navarro, JM ;
Rey, F ;
Bouhamdan, M ;
Spire, B ;
Vigne, R ;
Sire, J .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 261 (05) :599-606
[4]   HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [J].
Ayyavoo, V ;
Mahboubi, A ;
Mahalingam, S ;
Ramalingam, R ;
Kudchodkar, S ;
Williams, WV ;
Green, DR ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (10) :1117-1123
[5]   Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein [J].
Bartz, SR ;
Vodicka, MA .
METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1997, 12 (04) :337-342
[6]   Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G(2) accumulation by a mechanism which differs from DNA damage checkpoint control [J].
Bartz, SR ;
Rogel, ME ;
Emerman, M .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2324-2331
[7]  
BEECK AOD, 1995, CELL GROWTH DIFFER, V6, P781
[8]   The Epstein-Barr virus bZIP transcription factor Zta causes G(0)/G(1) cell cycle arrest through induction of cyclin-dependent kinase inhibitors [J].
Cayrol, C ;
Flemington, EK .
EMBO JOURNAL, 1996, 15 (11) :2748-2759
[9]   HUMAN-IMMUNODEFICIENCY-VIRUS VPR PRODUCT IS A VIRION-ASSOCIATED REGULATORY PROTEIN [J].
COHEN, EA ;
DEHNI, G ;
SODROSKI, JG ;
HASELTINE, WA .
JOURNAL OF VIROLOGY, 1990, 64 (06) :3097-3099
[10]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944